Darion L. Heald

Internal Medicine
30 S Mario Capecchi Dr Rm 3N100
Salt Lake City, UT 84112

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications

Delivery of toll-like receptor agonists by complement C3-targeted liposomes activates immune cells and reduces tumour growth.

Delivery of toll-like receptor agonists by complement C3-targeted liposomes activates immune cells and reduces tumour growth.

Journal: Journal of drug targeting
Published: January 21, 2021

Opsoclonus After COVID-19 in an Infant.

Opsoclonus After COVID-19 in an Infant.

Journal: Pediatric neurology
Published: December 14, 2020
Showing 1-2 of 2

Last Updated: 09/26/2026